News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Thomas M. Penders, MS, MD

Articles by Thomas M. Penders, MS, MD

potential dangers associated with loperamide and kratom use

Medication-Assisted Treatment on a Budget: Two You Should Know

ByCornel N. Stanciu, MD, MRO,Samantha A. Gnanasegaram, MD,Thomas M. Penders, MS, MD

June 20th 2019

This CME discusses the opioid-like effects of loperamide and kratom and raises awareness of potential dangers associated with use.

Latest Updated Articles

Medication-Assisted Treatment on a Budget: Two You Should Know
June 20th 2019

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults

Evaluating Transdermal Asenapine in Schizophrenia

Empowering Patients and Expanding Formulation Options in Schizophrenia Care